These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18976304)

  • 1. Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression.
    Luan FL; Steffick DE; Gadegbeku C; Norman SP; Wolfe R; Ojo AO
    Am J Transplant; 2009 Jan; 9(1):160-8. PubMed ID: 18976304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance-a propensity score-matched study.
    Nehus EJ; Liu C; Lu B; Macaluso M; Kim MO
    Nephrol Dial Transplant; 2017 Aug; 32(8):1424-1431. PubMed ID: 28810723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression.
    Sureshkumar KK; Thai NL; Hussain SM; Ko TY; Marcus RJ
    Transplantation; 2012 Apr; 93(8):799-805. PubMed ID: 22290269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C.
    Luan FL; Schaubel DE; Zhang H; Jia X; Pelletier SJ; Port FK; Magee JC; Sung RS
    Transplantation; 2008 Jun; 85(11):1601-6. PubMed ID: 18551066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid-sparing maintenance immunosuppression is safe and effective after simultaneous liver-kidney transplantation.
    Weeks SR; Luo X; Toman L; Gurakar AO; Naqvi FF; Alqahtani SA; Philosophe B; Cameron AM; Desai NM; Ottmann SE; Segev DL; Garonzik-Wang J
    Clin Transplant; 2020 Oct; 34(10):e14036. PubMed ID: 32652700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.
    Luan FL; Steffick DE; Ojo AO
    Transplantation; 2011 Feb; 91(3):334-41. PubMed ID: 21242885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction type and outcomes for kidney graft and patient survival in recipients with prior lung transplantation in the United States.
    Riad S; Goswami U; Jackson S; Hertz M; Matas A
    J Heart Lung Transplant; 2020 Feb; 39(2):157-164. PubMed ID: 31837899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisone-free maintenance immunosuppression in obese kidney transplant recipients.
    Matas AJ; Vock DM
    Clin Transplant; 2019 Oct; 33(10):e13668. PubMed ID: 31310030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risk and mortality after kidney transplantation: a population-based study on differences between Danish centres using standard immunosuppression with and without glucocorticoids.
    Engberg H; Wehberg S; Bistrup C; Heaf J; Sørensen SS; Thiesson HC; Hansen JM; Svensson M; Green A; Marckmann P
    Nephrol Dial Transplant; 2016 Dec; 31(12):2149-2156. PubMed ID: 27587604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
    Liu YY; Li CP; Huai MS; Fu XM; Cui Z; Fan LL; Zhang S; Liu Y; Ma J; Li G; Shen ZY
    PLoS One; 2015; 10(3):e0120939. PubMed ID: 25816221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid maintenance in repeat kidney transplantation: influence of induction agents on outcomes.
    Sureshkumar KK; Hussain SM; Nashar K; Marcus RJ
    Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):741-9. PubMed ID: 24969182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression.
    Rajab A; Pelletier RP; Henry ML; Ferguson RM
    Clin Transplant; 2006; 20(5):537-46. PubMed ID: 16968478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
    Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of maintenance steroids on the outcomes in deceased-donor kidney transplant recipients exposed to prolonged pretransplantation dialysis.
    Sureshkumar KK; Hussain SM; Thai NL; Marcus RJ
    Transplant Proc; 2013; 45(1):99-101. PubMed ID: 23375281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
    Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
    Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival.
    Younas N; Wu CM; Shapiro R; McCauley J; Johnston J; Tan H; Basu A; Schaefer H; Smetanka C; Winkelmayer WC; Unruh M
    BMC Nephrol; 2010 Apr; 11():5. PubMed ID: 20359353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transplant mortality and graft failure after induction immunosuppression among Black heart transplant recipients in the United States.
    Salia S; Mostofsky E; Gupta S; Lehman L; Barrera FJ; Liou L; Motiwala SR; Mittleman MA
    Am J Transplant; 2022 Nov; 22(11):2586-2597. PubMed ID: 35758522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary pediatric live-donor-kidney transplant-recipients' outcomes by immunosuppression induction received in the United States.
    Riad S; Jackson S; Chinnakotla S; Verghese P
    Pediatr Transplant; 2021 Aug; 25(5):e13925. PubMed ID: 33333629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.